The store will not work correctly when cookies are disabled.
With new Brexit regulation, carriers might ask you to pay clearances duties &
taxes invoices, or to provide the VAT exemption certificate.
More information.
Eschwege, Germany - June 27, 2024 – MP Biomedicals, a global leader in life sciences and diagnostic solutions, is proud to announce the launch of its innovative range of gastrointestinal diseases diagnostic kits. These state-of-the-art diagnostic solutions are designed to provide rapid, accurate, and reliable detection of a wide range of gastrointestinal conditions, enhancing patient care and advancing clinical research.
MP Biomedicals has launched MagBeads FastDNAâ„¢ and FastRNAâ„¢ Kits. which offer scalability for seamless transitions from proof-of-concept to larger studies, supporting both manual and automated workflows. Utilizing magnetic bead-based technology, these kits ensure efficient extraction of DNA/RNA with high purity, yield, and integrity, ready for immediate use in downstream applications.
MP Biomedicals has launched SPINeasy Nucleic Acid Extraction Kits, offering highly pure DNA and RNA for molecular biology applications. The kits are fast, efficient, and suitable for various sample types, demonstrating MP Bio's commitment to quality.
Exciting News! MP Biomedicals has been honoured with the prestigious "Emerging Brand of the Year" award at the Vaccine Leader Conclave on 22nd of August 2023 in Mumbai, a momentous event attended by industry luminaries, and organized by Bluetech Media.
The customer, a tissue processor, a company that manufactures tissue grafts and biologics from donated human musculoskeletal tissues, was utilizing a gentamicin sulfate solution, an antibiotic that inhibits the growth of a wide variety of Gram-positive and Gram-negative microorganisms, as part of their aseptic manufacturing process.
Our rapid tests for COVID antigens detection as well as IgG and IgM antibodies assessment have already proved their worth on the European market and abroad. MP Biomedicals will continue to serve its mission of advancing the world of health. Accordingly, MP Biomedicals focused on developing immunochromatographic assays for respiratory infectious disease detection.
In this line, we are happy to launch a group of three IVD rapid tests dedicated for the in vitro qualitative detection of 2019-nCoV, influenza type A, and influenza type B antigens. These tests are CE-marked and for professional use only.
MP Biomedicals, LLC has recently expanded its portfolio of COVID-19 related research products to include a wide selection of highly pure SARS-CoV-2 recombinant proteins, monoclonal antibodies specific and potent against a variety of SARS-CoV-2 protein domains, and high-quality ELISA kits to quantify SARS-CoV-2 and the virus-triggered human IgM and IgG antibodies.
Eschwege, Germany: September 13th, 2022- For more than 30 years, MP Diagnostics, a division of MP Biomedicals, has been committed to providing superior products, quality, and service at a competitive price. All MP Diagnostics products are produced under ...
